Company Search:
Advanced Search
Sponsored Links
Co Don AG Company Snapshot
Co Don AG operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Co Don AG with three other pharmaceutical manufacturers in Europe: Erytech Pharma SA of France (2016 sales of 4.14 million Euro [US$5.08 million] of which 100% was Pharmacy), Byotrol PLC of the United Kingdom (£2.65 million [US$3.69 million] of which 54% was Professional), and Curasan AG (6.50 million Euro [US$7.99 million] ).

Sales Analysis. Co Don AG reported sales of 5.60 million Euro (US$6.88 million) for the year ending December of 2016. This represents an increase of 10.1% versus 2015, when the company's sales were 5.09 million Euro. Sales at Co Don AG have increased during each of the previous five years (and since 2011, sales have increased a total of 142%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Co Don AG
  Stock Performance Chart for Co Don AG
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 6.96
(Figures in Euro)
1 Week -3.7%   13 Weeks -11.0%  
4 Weeks -10.4%   52 Weeks 60.4%  
Co Don AG Key Data:
  Ticker: CNWK Country: Germany
  Exchanges: FRA OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 5,597,813
(Year Ending Jan 2017).
Employees: 77
  Currency: Euro Market Cap: 123,133,870
  Fiscal Yr Ends: December Shares Outstanding: 17,691,648
  Share Type: Stammaktie Closely Held Shares: 6,411,322
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.